Changes of circulating transforming growth factor-β1 level during radiation therapy are correlated with the prognosis of locally advanced non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 5, Issue 4, 2010, Pages 521-525

  Zhao, Lujun ^a,b   Ji, Wei ^a,c   Zhang, Li ^a,d   Ou, Guangfei ^a   Feng, Qinfu ^a   Zhou, Zongmei ^a   Lei, Mingfang ^a   Yang, Weizhi ^a   Wang, Luhua ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Non small cell lung cancer; Prognosis; Radiation therapy; Transforming growth factor 1

Indexed keywords

CARBOPLATIN; GEMCITABINE; NAVELBINE; PACLITAXEL; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PLASMA; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RISK ASSESSMENT;

EID: 77951013233     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181cbf761     Document Type: Article

References (23)

1. Zhao L, West BT, Hayman JA, et al. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2007;68:103-110. (Pubitemid 46589842)
2. Hayman JA, Martel MK, Ten Haken RK, et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol 2001;19:127-136. (Pubitemid 32063489)
3. Yorke ED, Jackson A, Rosenzweig KE, et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 2005;63:672-682. (Pubitemid 41400051)
4. Grills IS, Yan D, Martinez AA, et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 2003;57:875-890. (Pubitemid 37194316)
5. Kong FM, Ten Haken RK, Schipper MJ, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/ unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005; 63:324-333.
6. Sheu BC, Chang WC, Cheng CY, et al. Cytokine regulation networks in the cancer microenvironment. Front Biosci 2008;13:6255-6268.
7. Zhao L, Sheldon K, Chen M, et al. The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer 2008;59:232-239. (Pubitemid 351173403)
8. Anscher MS, Kong FM, Jirtle RL. The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy. Lung Cancer 1998;19:109-120. (Pubitemid 28161303)
9. Zhao L, Wang L, Ji W, et al. Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan. Int J Radiat Oncol Biol Phys 2009;74:1385-1390.
10. Takayama S, Hatori M, Kurihara Y, et al. Inhibition of TGF-beta1 suppresses motility and invasiveness of oral squamous cell carcinoma cell lines via modulation of integrins and down-regulation of matrixmetalloproteinases. Oncol Rep 2009;21:205-210.
11. Sun L. Tumor-suppressive and promoting function of transforming growth factor beta. Front Biosci 2004;9:1925-1935. (Pubitemid 38918642)
12. Vicent S, Luis-Ravelo D, Anton I, et al. A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism. Cancer Res 2008;68:2275-2285. (Pubitemid 351521801)
13. Takanami I, Tanaka F, Hashizume T, et al. Roles of the transforming growth factor beta 1 and its type I and II receptors in the development of a pulmonary adenocarcinoma: results of an immunohistochemical study. J Surg Oncol 1997;64:262-267. (Pubitemid 27190813)
14. Saji H, Nakamura H, Awut I, et al. Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues. Ann Thorac Cardiovasc Surg 2003;9:295-300.
15. Hasegawa Y, Takanashi S, Kanehira Y, et al. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 2001; 91:964-971.
16. + regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients]. Zhonghua Zhong Liu Za Zhi 2007;29:922-926.
17. Vujaskovic Z, Groen HJ. TGF-beta, radiation-induced pulmonary injury and lung cancer. Int J Radiat Biol 2000;76:511-516. (Pubitemid 30232450)
18. Kong F, Jirtle RL, Huang DH, et al. Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma. Cancer 1999;86:1712-1719. (Pubitemid 29513039)
19. Zhao L, Wang L, Ji W, et al. Association between plasma angiotensinconverting enzyme level and radiation pneumonitis. Cytokine 2007;37: 71-75. (Pubitemid 46575290)
20. Wang L, Correa CR, Hayman JA, et al. Time to treatment in patients with stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2009;74:790-795.
21. Wang L, Correa CR, Zhao L, et al. The effect of radiation dose and chemotherapy on overall survival in 237 patients with stage III nonsmall- cell lung cancer. Int J Radiat Oncol Biol Phys 2009;73:1383-1390.
22. Pardali K, Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 2007; 1775:21-62. (Pubitemid 44881193)
23. Anscher MS, Kong FM, Andrews K, et al. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 1998;41:1029-1035. (Pubitemid 28377483)